Abstract
Keywords
Glaucium grandiflorum var. grandiflorum Antioxidant Anti-cholinesterase Anti-inflammatory DNA protecting activity
Introduction
Alzheimer’s disease (AD) is a progressive degenerative neurologic disorder resulting in impaired memory and behavior. The inhibition of acetylcholinesterase (AChE) has been one of the most used strategies for the treatment of AD (1). Many plant-derived alkaloids that act as AChE inhibitors (AChE-I) are available for the symptomatic treatment of patients with mild to moderate AD and can be considered as models for the development of anti-Alzheimer drugs. However, there is still a need for the discovery of more effective compounds with lower toxicity and higher central nervous system penetration (2). Furthermore, compounds possessing not only the AChE inhibitory properties, but also anti-inflammatory or antioxidant properties, are considered attractive because of the possibility to create multitargeted drugs acting with different mechanisms all related to the disease (2). Plant families that have been considered as potential sources of alkaloids are Amaryllidaceae, Buxaceae, Apocynaceae, Papaveraceae, Lycopodiaceae, and Leguminosae (2). The genus Glaucium (Papaveraceae) is of interest because of its medicinally important alkaloids. The species of Glaucium have been used in traditional medicine as laxative, hypnotic, and antidiabetic agents. The leaves of the species of Glaucium are also used in the treatment of dermatitis (3). There have been previous studies on the different Glaucium species demonstrating effects of potential interest in AD therapy, including antioxidant, anti-inflammatory, and anti-cholinesterase activities (3- 6)
Glaucium grandiflorum Boiss. & Huet is a perennial herb indigenous to various regions of the Middle East extending from the Eastern Mediterranean to Iran (7). In Turkey, Glaucium grandiflorum has two varieties as var. grandiflorum and var. torquatum, of which the latter is indigenous to Turkey (8). The fruits of G. grandiflorum have been used as folk medicine in Turkey for the purification of blood and in the treatment of opthalmic diseases. It is also reported that the sap of this plant have been used widely in Iran for the same purpose [9]. The therapeutic benefit of the plant is often attributed to its alkaloids.
Previous investigations on the alkaloids of G. grandiflorum revealed the existence of protoberberine, protopine, aporphine, and benzophenanthridine type alkaloids (7, 9-11). Prior findings on the alkaloids of Turkish samples of G. grandiflorum Boiss. & Huet var. grandiflorum collected from three different parts of Anatolia were as follows: Protoberberine ((-)-α-N- methylcanadine, (-)-β-N- methylcanadine), protopine (allocryptopine, protopine), aporphine (isocorydine, corytuberine, corydine), benzylisoquinoline ((+)-reticuline, and berbithine) type alkaloids (9, 11).
The reported anti-inflammatory and analgesic activities of the aerial parts of G. grandiflorum were related partly to the glaucine and tetrahydropalmatine alkaloids (3)
The present study aimed to evaluate the possible antioxidant, anti-inflammatory, AChE inhibitory and DNA protecting activities of G. grandiflorum var. grandiflorum collected from Doruksaray in Erzincan. Phytochemical investigations have been carried out on this collection and allocryptopine, protopine have been isolated as major alkaloids. The minor alkaloids have been proven to be (-)-α-N- methylcanadine, (-)-β-N- methylcanadine, (+) -reticuline, and berbithine (9).
Experimental
Plant material and chemicals
The aerial parts of G. grandiflorum var. grandiflorum were collected from Doruksaray in Erzincan (Turkey) in June 2013. Voucher specimens were deposited in the Herbarium of Istanbul University, Faculty of Pharmacy, Istanbul, Turkey (ISTE 101801).
For the assessment of antioxidant activity, soybean L-α-phosphatidylcholine Type IV-S,2,2-diphenyl-1-picrylhydrazyl(DPPH), α1-antitrypsin from human plasma, elastase from porcine pancreas, N-succinyl-ala-ala-ala-p-nitroanilide and NaOCl were purchased from Sigma-Aldrich (St. Louis, MO, USA); 2,2’-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt (ABTS), and rutin were purchased from Fluka (Buchs, Switzerland); L-ascorbic acid, 2,4,6-tripyridyl-S-triazine (TPTZ), thiobarbituric acid (TBA), trichloroacetic acid (TCA), iron (II) sulfate heptahydrate and ferric chloride were purchased from Merck (Darmstadt, Germany).
For the assessment of AChE inhibitory activity, acetylthiocholine iodide (ATChI), AChE, 5,5′-dithiobis (2-nitrobenzoic acid) (DTNB) and galantamine hydrobromide were purchased from Sigma-Aldrich (St. Louis, MO, USA).
For the assessment of cyclooxygenase (COX)-2 inhibitory activity, enzyme immunoassay (EIA) kit (560131) and indomethacin were obtained from Cayman (Ann Arbor, MI, USA).
The DNA protecting activity was assessed using the pBR322 plasmid purchased from Thermo Scientific (Fisher Scientific, Pittsburgh, PA, USA).
Preparation of the extract
The aerial parts of the plant were dried in shade at room temperature then powdered using a blender. 20 g of dried and powdered aerial parts of the plant were extracted with 450 mL of MeOH 70% with continuous stirring for 3 days at room temperature. Finally, the extract was evaporated to dryness under reduced pressure at 40 ºC in a rotary evaporator. The crude extract was lyophilized (2 g) and kept at -20 °C until used. For the assessment of activities, the extracts were dissolved in metanol. All the analyses were performed using a microplate reader (Biotek, Winooski, VT, USA).
Determination of the total phenolic compounds
Phenolic compounds in the extract of G. grandiflorum were estimated by a colorimetric assay, based on procedure described by Slinkard and Singleton (12). The results were expressed as mg gallic acid equivalents (GAE)/g of dry weight (DW).
Determination of the total flavonoid content
Total flavonoid content was determined by using a colorimetric method described by Sakanaka et al. (13). The results were expressed as mg of (+)-catechin equivalents (CE) per g of DW.
Determination of the total antioxidant activity
The antioxidant activity of the extract was compared to that of rutin, the most representive flavonol for phenolic plants.
Inhibition of lipid peroxidation
(LPO). LPO assay was based on the method described by Duh et al. (14). The formation of LPO products was assayed by the measurement of thiobarbituric acid reactive substances (TBARS) levels on the basis of malondialdehyde (MDA) reaction with TBA at 532 nm according to Buege and Aust (15). The percentage inhibition of LPO was calculated by comparing the results of the sample with those of controls not treated with the antioxidant using the following equation:
Inhibition effect (%) = (1 - Absorbance of sample at 532 nm) x 100.
Absorbance of control at 532 nm
The DPPH• scavenging activity of the extract was measured according to the procedure described by Brand-Williams et al. (16) and calculated by the following equation:
DPPH• scavenging activity (%) = (1 - Absorbance of sample at 517 nm/Absorbance of control at 517 nm) x 100.
Total radical-trapping antioxidant potential (TRAP) assay.TRAP of the extract was measured using the trolox equivalent antioxidant capacity (TEAC) assay as described by Re et al. (17). The ability to scavenge ABTS radical cation (ABTS•+) was calculated by the following equation:
ABTS•+ scavenging activity (%) = (1 - Absorbance of sample at 734 nm/Absorbance of control at 734 nm) x 100.
Ferric reducing antioxidant power (FRAP) assay. The FRAP assay was carried out according to the procedure of Benzie and Strain (18). The standard curve was constructed using iron sulfate heptahydrate solution (0.125 – 2 mM), and the results were expressed as mM Fe 2+ equivalents. Scavenging of hypochlorous acid (HOCl) (antitrypsin protection assay). Reaction with hypochlorous acid was studied using elastase assay as described by Murcia et al. (19). HOCl was prepared immediately before use by adjusting NaOCl solution to pH 6.2 with dilute H2SO4, and its concentration was measured spectrophotometrically at 235 nm, assuming a molar extinction coefficient of 100. HOCl scavenging activity was quantified as inhibition of the inactivation of α1-antitrypsin by HOCl. α1-Antitrypsin activity was measured indirectly as elastase activity with N-succinyl-ala-ala-ala-p-nitroaniline as substrate, since elastase is inhibited by α1-antitrypsin (20). The results were expressed as percentage inhibition of elastase activity with respect to the reaction mixture without test compound (saline only).
Inhibition (%) = (1 - Reaction rate of sample at 410 nm/ Reaction rate of control at 410 nm) x 100.
Determination of AChE inhibitory activity
The extract was screened for its AChE inhibitory activity through the modified Ellman’s spectrophotometric method (21). Galantamine hydrobromide was used as a standard.
Inhibition of AChE (%) = (1 - Reaction rate of sample at 412 nm/ Reaction rate of control at 412 nm) x 100.
COX-2 inhibitory activity
The ability of the extract to inhibit recombinant human COX-2 was determined by calculating percent inhibition of prostaglandin production using an enzyme immunoassay (EIA) kit according to the manufacturer’s instructions (Cayman, USA).
DNA nicking assay
DNA-protecting activity of the lyophilized methanolic extract of the aerial parts of G. grandiflorum var. grandiflorum from devastating effects of hydroxyl radicals generated by Fenton reagent was evaluated by DNA nicking assay described by Lee et al. (22). DNA nicking assay was performed using pBR322 plasmid DNA. The reaction mixture contained 0.5 μg plasmid DNA, Fenton’s reagent (30 mM H2O2, 50 µM ascorbic acid, and 80 µM FeCl3) followed by the addition of extracts and the final volume of the mixture was brought up to 20 μL using distilled water. The mixture was then incubated for 30 min at 37 °C. The DNA was analyzed on 1% agarose gel using ethidium bromide staining. Densitometric analysis was performed by using BIO1D software.
Statistical analysis
All measurements were made in triplicate. The results were evaluated using unpaired t-test with NCSS statistical computer package and expressed as mean ± standard deviation. Differences were considered significant at p < 0.05.
Results and Discussion
Total extractable compounds, total phenolic and flavonoid contents of lyophilized methanolic extract obtained from the aerial parts of G. grandiflorum var. grandiflorum are shown in Table 1. The total phenolic content of the extract was found to be 3.54 ± 0.11 mg, in terms of GAE per gram of DW of the sample. The total flavonoid content of the extract was found to be 3.15 ± 0.14 mg, in terms of CE/g of DW of the sample. Previous investigations on phenolic compounds of G. aleppicum (6) revealed significantly higher levels of total polyphenols (18.8 GAE mg/g DW) compared to that of G. grandiflorum var. grandiflorum. Since earlier studies revealed that one of the more prominent properties of the flavonoids is their excellent radical scavenging ability (23), it has been proposed that the active constituents contributing to the antioxidant activity of the extract are the polyphenolic substances, particularly flavonoids.
Total extractable compounds (EC), total phenolic compounds (PC) (as gallic acid equivalents) and total flavonoids (as catechin equivalents) in the lyophilized methanol extract from the aerial parts of G. grandiflorum var. grandiflorum
Extract | EC | PC | Flavonoid |
---|---|---|---|
G. grandiflorum var. grandiflorum | 0.1 | 3.54 0.11 | 3.15 0.14 |
Antioxidant activities of the lyophilized methanolic extract from the aerial parts of G. grandiflorum var. grandiflorum
AChE inhibitory activity of the lyophilized methanolic extract from the aerial parts of G. grandiflorum var. grandiflorum
Extract | AChE inhibitory activity (%) | EC50 (mg/mL) | ||
---|---|---|---|---|
0.32 mg/Ml | 0.16 mg/mL | 0.08 mg/mL | ||
G. grandiflorum var. grandiflorum | 80.75 1.59 | 59.97 0.39 | 43.22 1.97 | 0.12 0.01 |
25 μg/mL | 12.5 μg/mL | 6.25 μg/mL | EC50 (μg/mL) | |
Galantamine | 82.23 2.21 | 71.02 3.56 | 47.94 1.40 | 7.07 0.5 |
Hypochlorous acid scavenging activity of the lyophilized methanolic extract from the aerial parts of G. grandiflorum var. grandiflorum, determined in antitrypsin protection assay
Extract | Elastase inhibitory activity (%) | |||
---|---|---|---|---|
10 mg/mL | 5 mg/mL | 2.5 mg/mL | EC50 (mg/mL) | |
G. grandiflorum var. grandiflorum | 92.73 1.4 | 45.06 1.4 | 10.50 2.5 | 5.87 0.07 |
0.625 mg/mL | 0.31 mg/mL | 0.16 mg/mL | EC50 (mg/mL) | |
Vitamin C | 83.01 2.33 | 56.23 1.75 | 17.93 0.71 | 0.35 0.019 |
COX-2 inhibitory activity of the lyophilized methanolic extract from the aerial parts of G. grandiflorum var. grandiflorum
Extract | COX-2 inhibitory activity (%) | |||
---|---|---|---|---|
10 mg/mL | 5 mg/mL | 2.5 mg/mL | EC50 (mg/mL) | |
G. grandiflorum var. grandiflorum | 72.39 2.9 | 46.87 1.6 | 19.21 0.9 | 6.39 0.1 |
40 g/mL | 20 g/mL | 10 g/mL | EC50 (g/mL) | |
Indomethacin | 92.13 1.3 | 58.66 1.1 | 34.41 0.6 | 17.11 0.41 |
Antioxidant activities of the extract were expressed as half maximal effective concentration (EC50), TEAC, and FRAP values and presented in Table 2.
A well-recognized result of oxidant injury is peroxidation of membrane lipids to organic peroxyl radicals which initiates a chain reaction that may explain many membrane-mediated effects of reactive oxygen species (ROS). At 5 mg/mL the extract showed 75.85 ± 1.44% inhibitory effect on LPO. Similarly, the methanol extracts of G.contortuplicatum, G. elegans and G. fimbrilligerum were reported to show 55.18 ± 2.41%, 61.76 ± 1.23% and 89.16 ± 8.01%, respectively, linoleic acid peroxidation inhibition, using 40 μg of plant extract in the reaction mixture (4). Based on the EC50 values, the anti-LPO activity of the extract was significantly lower (p < 0.05) with an EC50 value of 2.62 ± 0.08 mg/mL in comparison with rutin (0.76 ± 0.03 mg/mL). Souri et al. (4) reported the higher inhibitory activity of lyophilized methanolic extracts of G. contortuplicatum, G. elegans and G. fimbrilligerum with an average IC50 value of 8.68 ± 2.63, 14.20 ± 0.61 and 4.19 0.78 µg/mL, respectively.
The extract showed appreciable DPPH scavenging activity (EC50 = 2.03 ± 0.17 mg/mL), but this activity was considerably (p < 0.05) lower than that obtained with the reference antioxidant, rutin (EC50 = 0.150 ± 0.07 mg/mL).
The extract exhibited ABTS•+ scavenging activity of 2.11 ± 0.015 mM Trolox equivalents or 21.1 mM of Trolox per gram of DW at 10 mg/mL, was nearly equal to that of rutin (2.11 ± 0.005 mM) at 1.25 mg/mL and may be attributed to its electron-transfer abilities. Based on the EC50 values, ABTS•+ scavenging activity of the extract was significantly lower (p < 0.05) with an EC50 value of 4.80 ± 0.14 mg/mL in comparison with rutin (0.58 ± 0.02 mg/mL). In comparison to the methanolic extract obtained from G. aleppicum which showed 81.2 µM TEAC/g DW (6), it was evident that G. grandiflorum var. grandiflorum methanol extract is stronger antioxidant.
The FRAP assay measures the ability of the extracts to reduce TPTZ-Fe (III) complex to TPTZ-Fe (II) complex. It was found that at 10 mg/mL the lyophilized methanolic extract from G. grandiflorum var. grandiflorum possesses high reducing power (FRAP value = 2.45 ± 0.07 mM Fe2+) similar to that of rutin at 1.25 mg/mL (FRAP value = 2.53 ± 0.01 mM Fe2+).
The plant kingdom, an important source of several drugs or “lead compounds” for medicinal chemistry, is still largely unexplored despite the relatively large amount of tested plant extracts for AChE-I (2).
Since Glaucium species was found to be rich in alkaloids as active constituents that significantly contribute to their neuroprotective properties, the AChE inhibitory activity of the extract was also examined in this study. The extract showed the remarkable AChE inhibitory activity of 80.75 ± 1.59% at 0.32 mg/mL, which was comparable to that of galantamine (82.23 ± 2.21%) at a concentration of 25 μg/mL (Table 3). Compared with the data presented by Orhan et al. (5), the AChE inhibitory properties of the extracts of G. grandiflorum var. grandiflorum was similar to that of the chloroform:methanol (1:1); extract of the G. corniculatum (above 86.55 ± 0.67 inhibition rate at 1mg/mL). Based on the EC50 values, the AchE inhibitory activity of the extract was significantly lower (p < 0.05) with an EC50 value of 0.12 ± 0.01 mg/mL in comparison with galantamine (7.07 ± 0.5 µg/mL) (Table 3).
At chronic inflammation, activated neutrophils release H2O2 and the enzyme myeloperoxidase, catalyzing the formation of HOCl. It deactivates serine protease inhibitors such as α1-antitrypsin, α2-macroglobulin, plasminogen activator inhibitor, and tissue inhibitor of metalloproteinases 1 (20).
The mean elastase activity in the reaction mixture without test extract was 8.90 U/mL (A410 = 0.500). Elastase activity was inhibited 92.73% by the lyophilized methanolic extract of G. grandiflorum var. grandiflorum at 10 mg/mL (Table 4). Rutin showed no detectable HOCl scavenging activity. According to Murcia et al. (19) vitamin C is very good HOCl scavenger. Although the extract was less effective than the positive control, vitamin C, it is able to react with HOCl and thus to protect α1-antiproteinase against inactivation. Based on the EC50 values, the elastase inhibitory activity of the extract was significantly lower (p < 0.05) with an EC50 value of 5.87 0.07 mg/mL in comparison with vitamin C (0.35 ± 0.019 mg/mL) (Table 4).
Lyophilized methanolic extract of the aerial parts of G.grandiflorum var. grandiflorum was tested for its COX-2 inhibitory activity in comparison with indomethacin used as the positive control. COX-2, which is induced in response to inflammation, is important pharmacological target for the development of new drugs to treat chronic inflammatory diseases (24). The ability of the extracts to inhibit COX-2 was determined by calculating percent inhibition of prostaglandins production. At a concentration of 10 mg/mL, the extract showed inhibitory effect of 72.39%, but this activity was considerably (p < 0.05) lower than that of indomethacin. Based on the EC50 values, the COX-2 inhibitory activity of the extract was significantly lower (p < 0.05) with an EC50 value of 6.39 ± 0.1 mg/mL in comparison with indomethacin (17.11 ± 0.41 µg/mL) (Table 5).
The DNA nicking assay, which consisted of exposing a pBR322 plasmid DNA to the Fenton reaction, was designed to reveal increasing amounts of nicked and linear DNA in agarose gels. Addition of the lyophilized methanolic extract of G. grandiflorum var. grandiflorum resulted in a significant and dose dependent decrease in the formation of nicked DNA and it increased the supercoiled form of DNA. The plant extract showed maximum inhibition (94%) of plasmid DNA damage at 200 μg/mL, when the nicked form was normalized to the corresponding control treated with FR but no plant extract. The lowest extract dose tested (0.19 μg/mL) still inhibited DNA nicking by 25%. The concentration dependent protective activity of the plant extract is shown in
These results indicate that the G. grandiflorum var. grandiflorum extract is an excellent source of antioxidants that prevent DNA damage. To the best of our knowledge, no previous literature has reported the DNA protecting activity by G. grandiflorum var. grandiflorum. Therefore, the results reported here would appear to be the first report.
Conclusion
The antioxidative data presented in this study demonstrate that the lyophilized methanolic extract of G. grandiflorum var. grandiflorum is capable of scavenging some synthetic and naturally occurring free radicals, which indicates that the extract may have the potential to prevent free radical-mediated oxidative stress. Scavenging of HOCl and inhibition of COX-2 may contribute to the anti-inflammatory activities of the extract. The extract was also protective against DNA damage. Another important finding was the remarkable AChE inhibitory activity of the extract, which is of significant value in the pharmacological investigation for the treatment of AD.
References
-
1.
Filho JMB, Medeiros KCP, Diniz MFFM, Batista LM, Athayde-Filho PF, Silva MS, da-Cunha EVL, Almeida JRGS, Quintans-Júnior LJ. Natural products inhibitors of the enzyme acetylcholinesterase. Rev. Bras. Farmacogn. 2006;16:258-5.
-
2.
Dall’Acqua S. Plant-derived acetylcholinesterase inhibitory alkaloids for the treatment of Alzheimer’s disease. Bot. Targets. Ther. 2013;3:19-28.
-
3.
Morteza-Semnani K, Saeedi M, Hamidian M, Vafamehr H, Dehpour AR. Anti-inflammatory, analgesic activity and acute toxicity of Glaucium grandiflorum extract. J. Ethnopharmacol. 2002;80:181-6. [PubMed ID: 12007708].
-
4.
Souri E, Amin G, Dehmobed-Sharifabadi A, Nazifi A, Farsam H. Antioxidative activity of sixty plants from Iran. Iran. J. Pharm. Res. 2004;3:55-9.
-
5.
Orhan I, Sener B, Choudhary MI, Khalid A. Acetylcholinesterase and butyrylcholinesterase inhibitory activity of some Turkish medicinal plants. J. Ethnopharmacol. 2004;91:57-60. [PubMed ID: 15036468].
-
6.
Alali FQ, Tawaha K, El-Elimat T, Syouf M, El-Fayad M, Abulaila K, Nielsen SJ, Wheaton WD, Falkinham III JO, Oberlies NH. Antioxidant activity and total phenolic content of aqueous and methanolic extracts of Jordanian plants: an ICBG Project. Nat. Prod. Res. 2007;21:1121-31. [PubMed ID: 17852749].
-
7.
El-Afifi F, Al-Eisawi D, Al-Khalil S, Sciff JPL. Alkaloides of Glauciumgrandiflorum. J. Nat. Prod. 1986;49:1166-7.
-
8.
Cullen J Papaveraceae, Davis PH, editors. Flora of Turkey and The East Aegean Islands. vol. 1. Edinburgh: Edinburgh University Press; 1956. 213 p.
-
9.
Sarı A. The constituents of the aerial parts of G grandiflorum var grandiflorum. Acta Pharm. Turc. 2001;XLIII:89-92.
-
10.
Gözler T. Alkaloids of Turkish Glaucium Species. Planta Med. 1982;46:179-80. [PubMed ID: 17396968].
-
11.
Sariyar G, Unsal C. Alkaloids from G. grandiflorum var. grandiflorum. J. Fac. Pharm. Istanbul. 1998;32:55-8.
-
12.
Slinkard K, Singleton VL. Total phenol analysis: automation and comparison with manual methods. Am. J. Enol. Viticult. 1977;28:49-55.
-
13.
Sakanaka S, Tachibana Y, Okada Y. Preparation and antioxidant properties of extracts of Japanese persimmon leaf tea (kakinoha-cha). Food Chem. 2005;89:569-75.
-
14.
Duh PD, Tu YY, Yen GC Antioxidant activity of water extract of Harng Jyur (Chrysanthemum morifolium Ramat). LWT- Food Sci. Technol. 1999;32:269-77.
-
15.
Buege JA, Aust SD. Lipid peroxidation. Method Enzymol. 1978;52:302-10.
-
16.
Brand-Williams W, Cuvelier ME, Berset C. Use of a free radical method to evaluate antioxidant activity. LWT- Food Sci. Technol. 1995;28:25-30.
-
17.
Re R, Pellegrini N, Proteggente A, Pannala A, Yang M, Rice-Evans C. Antioxidant activity applying an improved ABTS radical cation decolorization assay. Free Radical Bio. Med. 1999;26:1231-7. [PubMed ID: 10381194].
-
18.
Benzie IFF, Strain JJ. The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": The FRAP assay. Anal. Biochem. 1996;239:70-6. [PubMed ID: 8660627].
-
19.
Murcia MA, Jiménez AM, Martínez-Tomé M. Evaluation of the antioxidant properties of Mediteranean and tropical fruits compared with common food additives. J. Food Protect. 2001:2037-46.
-
20.
Whiteman M, Rose P, Siau JL, Halliwell B. Nitrite-mediated protection against hypochlorous acid–induced chondrocyte toxicity A novel cytoprotective role of nitric oxide in the inflamed joint? Arthritis. Rheum. 2003;48:3140-50. [PubMed ID: 14613276].
-
21.
Ellman GL, Courtney KD, Andres V Jr, Feather-Stone RM. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 1961;7:88-95. [PubMed ID: 13726518].
-
22.
Lee JC, Kim HR, Kim J, Jang YS. Antioxidant property of an ethanol extract of the stem of Opuntia ficus-indica var. saboten. J. Agric. Food Chem. 2002;5:6490-6.
-
23.
Havsteen BH. The biochemistry and medical significance of the flavonoids. Pharmacol. Ther. 2002;96:67-202. [PubMed ID: 12453566].
-
24.
Calixto JB, Otuki MF, Santos AR. Anti-inflammatory compounds of plant origin Part I Action on arachidonic patway, nitric oxide and nuclear factor κB (NF-κB). Planta Med. 2003;69:974-83.